AbbVie Inc annual free cash flow for fiscal 2025 was $17.8 billion, a decrease of 0.1% from $17.8 billion in fiscal 2024. Trailing-twelve-month free cash flow is $19.9 billion. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | TTM | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | $19.9B | $17.8B | $17.8B | $22.1B | $24.2B | $22.0B | $16.8B | $12.8B | $12.8B | $9.4B | $6.6B | $7.0B | $2.9B | $5.8B | $6.0B | $5.9B | $4.5B | $5.1B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | $3.6B | $4.9B | $6.5B | $4.9B | $1.4B | $6.8B | $5.2B | $2.0B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More ABBV metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Shares Outstanding
All ABBV financial statements → Interactive ABBV charts →
About TickerBase · Data methodology & sources